Jan 29, 2024
Dr. Fiona Elwood, VP and Neurodegeneration Disease Area Stronghold leader at J&J Innovative Medicine discusses the challenges in developing new therapies for neurodegenerative diseases in part because of the heterogeneity of the patient population. She highlights the difficulty in defining the subsets of these...
Jan 29, 2024
Dr. Fiona Elwood, VP and Neurodegeneration Disease Area Stronghold leader at J&J Innovative Medicine discusses the challenges in developing new therapies for neurodegenerative diseases in part because of the heterogeneity of the patient population. She highlights the difficulty in defining the subsets of these...
Dec 13, 2023
Dr. Barnaby Balmforth, Co-Founder and CEO of Biofidelity, has a mission to make genomic analysis simpler, faster, and more reliable for treatment decisions. Biofidelity addresses genome sequencing challenges by using a targeted approach and unique technology that allows for local testing using PCR rather than...
Dec 13, 2023
Dr. Barnaby Balmforth, Co-Founder and CEO of Biofidelity, has a mission to make genomic analysis simpler, faster, and more reliable for treatment decisions. Biofidelity addresses genome sequencing challenges by using a targeted approach and unique technology that allows for local testing using PCR rather than...
Aug 9, 2023
Tuvik Beker, CEO, and Ranit Aharonov, CTO of Pangea Biomed, have designed ENLIGHT, a computational platform driving precision oncology that matches cancer tumors with available therapies. Drawing on an understanding of synthetic mortality and synthetic rescue, this approach focuses on how the interaction between genes...